INS and Hyperinsulinemia: In DM patients, insulin resistance leads to a compensatory increase in insulin secretion, and by inhibition of IGF binding proteins, this hyperinsulinemia may increase the biological activity of IGF-1, which is an antiapoptotic and mitogenic factor[49].